TransEnterix Inc. (TRXC)

0.96
AMEX : Commercial Services
Prev Close 0.95
Day Low/High 0.95 / 1.02
52 Wk Low/High 0.70 / 6.98
Avg Volume 2.32M
Exchange AMEX
Shares Outstanding 217.74M
Market Cap 206.85M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
TransEnterix Receives FDA 510(k) Clearance For 3mm Diameter Instruments

TransEnterix Receives FDA 510(k) Clearance For 3mm Diameter Instruments

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received FDA 510(k) clearance for 3 millimeter...

TransEnterix Provides Corporate Update

TransEnterix Provides Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including preliminary unaudited revenue for the...

TransEnterix Receives CE Mark Approval For Senhance Ultrasonic Instrument System

TransEnterix Receives CE Mark Approval For Senhance Ultrasonic Instrument System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for its Senhance...

TransEnterix Acquires Assets, Intellectual Property And Retains R&D Team From MST Medical Surgery Technologies

TransEnterix Acquires Assets, Intellectual Property And Retains R&D Team From MST Medical Surgery Technologies

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has acquired substantially all of the assets of MST Medical...

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix, Inc. (NYSE American:TRXC) announced today that TransEnterix will participate in two upcoming healthcare conferences: Todd M.

TransEnterix Announces FDA 510(k) Submission For Senhance Ultrasonic Instrument System

TransEnterix Announces FDA 510(k) Submission For Senhance Ultrasonic Instrument System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company filed a FDA 510(k) submission for its Senhance Ultrasonic...

TransEnterix, Inc. Appoints Eric Smith As Chief Commercial Officer

TransEnterix, Inc. Appoints Eric Smith As Chief Commercial Officer

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that Eric Smith has been named Chief Commercial Officer,...

TransEnterix To Present At The 13th Annual Wells Fargo Securities Healthcare Conference

TransEnterix To Present At The 13th Annual Wells Fargo Securities Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

TransEnterix, Inc. Reports Operating And Financial Results For The Second Quarter 2018

TransEnterix, Inc. Reports Operating And Financial Results For The Second Quarter 2018

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2018.

TransEnterix Schedules Second Quarter 2018 Financial And Operating Results Conference Call For August 7, 2018

TransEnterix Schedules Second Quarter 2018 Financial And Operating Results Conference Call For August 7, 2018

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release second quarter 2018 financial and operating results before the market opens on Tuesday, August 7, 2018.

September 21st Options Now Available For TransEnterix Inc (TRXC)

September 21st Options Now Available For TransEnterix Inc (TRXC)

Investors in TransEnterix Inc saw new options become available today, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new September 21st contracts and identified the following call contract of particular interest.

TransEnterix Provides Corporate Update

TransEnterix Provides Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today provided a corporate update, including the announcement of the sale of an...

TransEnterix, Inc. To Join The Russell 2000® Index

TransEnterix, Inc. To Join The Russell 2000® Index

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the company will be added to the Russell 2000 ® Index at the...

August 17th Options Now Available For TransEnterix (TRXC)

August 17th Options Now Available For TransEnterix (TRXC)

Investors in TransEnterix Inc saw new options become available today, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

TransEnterix Announces FDA 510(k) Submission For 3mm Senhance Instruments

TransEnterix Announces FDA 510(k) Submission For 3mm Senhance Instruments

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the Company filed a FDA 510(k) submission for additional Senhance...

TransEnterix Announces FDA Clearance For Expanded Indications For Senhance Surgical System

TransEnterix Announces FDA Clearance For Expanded Indications For Senhance Surgical System

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company has received FDA 510(k) clearance for expanded...

TransEnterix, Inc. Announces Loan Agreement With Hercules Capital

TransEnterix, Inc. Announces Loan Agreement With Hercules Capital

TransEnterix, Inc. (NYSE American: TRXC) (the "Company"), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has entered into a debt financing...

TRXC January 2019 Options Begin Trading

Investors in TransEnterix Inc saw new options begin trading today, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TransEnterix, Inc. Reports Operating And Financial Results For The First Quarter 2018

TransEnterix, Inc. Reports Operating And Financial Results For The First Quarter 2018

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the first quarter 2018.

TransEnterix Schedules First Quarter 2018 Financial And Operating Results Conference Call For May 8, 2018

TransEnterix Schedules First Quarter 2018 Financial And Operating Results Conference Call For May 8, 2018

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release first quarter 2018 financial and operating results after the market closes on Tuesday, May 8, 2018.

June 15th Options Now Available For TransEnterix (TRXC)

Investors in TransEnterix Inc saw new options begin trading today, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new June 15th contracts and identified the following call contract of particular interest.

TransEnterix To Showcase Senhance Surgical System At Society Of American Gastrointestinal And Endoscopic Surgeons 2018 Annual Meeting

TransEnterix To Showcase Senhance Surgical System At Society Of American Gastrointestinal And Endoscopic Surgeons 2018 Annual Meeting

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, will showcase the Senhance™ Surgical...

TransEnterix, Inc. Reports Operating Results For The Fourth Quarter And Full Year 2017

TransEnterix, Inc. Reports Operating Results For The Fourth Quarter And Full Year 2017

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial...

TransEnterix Schedules Fourth Quarter And Fiscal Year 2017 Financial And Operating Results Conference Call For March 6, 2018

TransEnterix Schedules Fourth Quarter And Fiscal Year 2017 Financial And Operating Results Conference Call For March 6, 2018

TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2017 financial and operating results after the market closes on Tuesday, March 6, 2018.

TransEnterix Announces FDA 510(k) Submission For Senhance Indication Expansion To More Than Double Addressable Market In The U.S. And Provides Commercial Update

TransEnterix Announces FDA 510(k) Submission For Senhance Indication Expansion To More Than Double Addressable Market In The U.S. And Provides Commercial Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company has filed a FDA...

TransEnterix To Present At The RBC Capital Markets 2018 Global Healthcare Conference

TransEnterix To Present At The RBC Capital Markets 2018 Global Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

TransEnterix To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

TransEnterix To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M.

March 16th Options Now Available For TransEnterix (TRXC)

March 16th Options Now Available For TransEnterix (TRXC)

Investors in TransEnterix Inc saw new options become available today, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new March 16th contracts and identified the following call contract of particular interest.

TransEnterix Provides 2017 Year End Corporate Update

TransEnterix Provides 2017 Year End Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today provided a year-end corporate update.

TheStreet Quant Rating: D- (Sell)